ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Malignancy"

  • 2019 American Transplant Congress

    Lower Incidence of Posttransplant Malignancies under Vitamin D (Calcidiol) Treatment in Kidney Transplantation

    I. Revuelta1, V. Tubita2, J. Ugalde1, D. Cucchiari1, F. Oppenheimer1, F. Diekmann1, J. Campistol1, J. Torregrosa1

    1Department of Nephrology and Kidney Transplant, Hospital Clinic, Barcelona, Spain, 2Experimental Laboratory of Nephrology and Kidney Transplant, IDIBAPS, Barcelona, Spain

    *Purpose: An increasing body of evidence has emerged on the role of 1α,25-dihydroxyvitamin D3[1,25(OH) 2 D] in cell differentiation, which seems to have regulation properties…
  • 2019 American Transplant Congress

    Kidney Transplant Outcomes in Patients with ESRD Due to Myeloma

    A. Riaz, A. Khalil, M. S. Yaqub, T. Taber, O. Adebiyi, A. Sharfuddin

    Indiana University School of Medicine, Indianapolis, IN

    *Purpose: Recent literature has suggested that certain patients with multiple myeloma can successfully undergo renal transplantation after stem transplantation with consideration for maintenance therapy. Outcomes…
  • 2019 American Transplant Congress

    Development and Characterization of Human-Derived Xenograft Model for Hepatocellular Carcinoma

    M. Nazzal1, R. Steele2, R. Ray3, N. Phillips2, J. Long4, R. Ray2

    1Surgery, Saint Louis University, Saint Louis, MO, 2Pathology, Saint Louis University, Saint Louis, MO, 3Internal Medicine, Saint Louis University, Saint Louis, MO, 4Comparative Medicine, Saint Louis University, Saint Louis, MO

    *Purpose: Hepatocellular carcinoma (HCC) is rising in the USA and treatment options are limited. There is no convenient animal model for HCC to study novel…
  • 2019 American Transplant Congress

    Long Term Follow-Up of the Use of Checkpoint Inhibitors in Kidney Transplant Recipients

    K. Venkatachalam, R. Delos Santos, T. Alhamad

    Transplant nephrology, Washington University, St. Louis, MO

    *Purpose: To report the long term impact of check point inhibitors in patient and allograft survival among kidney transplant recipients.*Methods: We report follow up of…
  • 2019 American Transplant Congress

    Hepatoblastoma Tumors Requiring Liver Transplantation Manifest Dysregulated Ciliary, Autophagy and Cell Cycling Pathways in Systems Biology Analysis

    T. Narayanan1, M. Ningappa2, B. W. Higgs2, S. Subramaniam3, R. Sindhi2

    1Bioenginering, University of California, San Diego, CA, 2Childrens Hospital of Pittsburgh of UPMC, Pittsburgh, PA, 3University of California, San Diego, CA

    *Purpose: Liver transplantation (LT) can cure locally invasive, unresectable and chemo-resistant hepatoblastoma (HBL), an embryonal liver tumor of infancy. Post-LT immunosuppression enhances recurrence-risk despite chemotherapy.*Methods:…
  • 2019 American Transplant Congress

    Pathologic Vascular Invasion Correlates with Worse Outcome in Hepatoblastoma Patients Treated with Liver Transplantation – A Hepatoblastoma Transplant Consortium Study

    T. H. Malik1, H. Zhu2, T. Ha3, S. Commander4, C. Trautz5, R. Sindhi5, S. Kim6, K. Vakili6, N. Vachharajani7, W. Chapman7, A. Griesemer8, M. Martinez8, J. A. Goss9, S. Vasudevan10

    1Baylor College of Medicine, Houston, TX, 2Texas Children's Hospital, Houston, TX, 3Department of Surgery, Baylor College of Medicine, Houston, TX, 4Department of Surgery, Duke University School of Medicine, Durham, NC, 5Department of Surgery, University of Pittsburgh, Pittsburgh, PA, 6Department of Surgery, Boston Children's Hospital, Boston, MA, 7Department of Surgery, Washington University School of Medicine in St. Louis, St. Louis, MO, 8Department of Surgery, NewYork-Presbyterian Morgan Stanley Children's Hospital, New York, NY, 9Division of Abdominal Transplantation, Baylor College of Medicine, Houston, TX, 10Department of Pediatric Surgery, Texas Children's Hospital, Houston, TX

    *Purpose: Orthotopic liver transplant (OLTx) is the most common method to treat unresectable hepatoblastoma (HB) in children. There is limited data focusing on the outcomes…
  • 2019 American Transplant Congress

    Relationship between Comorbilities and Infectious Disease in Kidney Transplant Recipients Receiving Rituximab

    A. Molina-Andújar1, E. Hermida1, J. Rovira2, F. Cofan1, P. Ventura-Aguiar1, N. Esforzado1, V. Torregrosa1, D. Cucchiari1, E. de Souza1, I. Revuelta1, F. Oppenheimer1, F. Diekmann1, G. Piñeiro1

    1Renal Transplant Unit, Hospital Clínic de Barcelona, Barcelona, Spain, 2Laboratori Experimental de Nefrologia i Trasplantament, IDIBAPS, Barcelona, Spain

    *Purpose: Rituximab is commonly used in the context of kidney transplantation. Evidence about infectious complications and its relationship with predictive factors is scarce. The aim…
  • 2019 American Transplant Congress

    The Safety Of Adjuvant Chemotherapy In Kidney Transplant Patients With Urothelial Carcinoma

    Z. Wang, J. Xiao, Y. Zhu, J. Lin, Y. Guo, Y. Tian

    Capital Medical University,Beijing Friendship Hospital, Beijing, China

    *Purpose: The purpose of the present study was to evaluate the safety of adjuvant chemotherapy with gemcitabine plus cisplatin in kidney transplant patients with urothelial…
  • 2019 American Transplant Congress

    The Response to Human Papillomavirus Vaccination in Pediatric Patients before and after Kidney Transplantation

    C. Nailescu1, R. D. Nelson2, K. Twombley3, P. S. Verghese4, A. S. Chishti5, M. Mills6, J. E. Slaven7, J. D. Mahan8, M. L. Shew1

    1Riley Hospital for Children, Indianapolis, IN, 2Primary Children’s Hospital, Salt Lake City, UT, 3MUSC Children’s Hospital, Charleston, SC, 4Children’s Hospitals and Clinics of Minnesota, Minneapolis, MN, 5Kentucky Children’s Hospital, Lexington, KY, 6C.S. Mott Children’s Hospital, Ann Arbor, MI, 7Indiana University, Indianapolis, IN, 8Nationwide Children’s Hospital, Columbus, OH

    *Purpose: Kidney transplant (KT) recipients have an increased incidence of malignancies, including Human Papillomavirus (HPV)-associated cancers. Thus, HPV vaccines may have an important role in…
  • 2018 American Transplant Congress

    A Population Based Study of Incidence of Post Kidney Transplant Malignancies

    D. Sexton,1 J. O'Neill,2 P. O'Kelly,1 S. Murray,1 S. Deady,3 E. O'Leary,3 P. Morris,4 P. Conlon.1

    1Department of Nephrology & Transplantation, Beaumont Hospital Dublin, Royal College of Surgeons Ireland, Dublin, Ireland; 2Department of Otolaryngology, Head and Neck Surgery, Beaumont Hospital, Dublin, Ireland; 3National Cancer Registry Ireland, Cork, Ireland; 4Department of Oncology, Beaumont Hospital, Dublin, Ireland.

    IntroductionWe aimed to report national standardised incidence for malignancy post transplant compared to the general population stratified by solid organ categories. In this study we…
  • « Previous Page
  • 1
  • …
  • 8
  • 9
  • 10
  • 11
  • 12
  • …
  • 20
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences